España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Goldman Sachs Group Inc.
Healthcare ETFs Unmoved By Possible Humana Inc. Merger
Saks and Neiman Marcus Merger at the Rumor Stage
UPDATE: Goldman Sachs Reiterates Buy Rating, Lowers PT for Cliffs Natural Resources
Saks and Neiman Marcus Merger at the Rumor Stage
UPDATE: Goldman Sachs Reiterates Buy Rating, Lowers PT for Cliffs Natural Resources
Goldman Sachs Reiterates Neutral Rating, $1.90 PT for Rite Aid
UPDATE: Goldman Sachs Reiterates Sell Rating, Lowers PT for Progressive Corporation
Goldman Sachs Reiterates Neutral Rating, $1.90 PT for Rite Aid
UPDATE: Goldman Sachs Reiterates Sell Rating, Lowers PT for Progressive Corporation
Goldman Sachs Reiterates Sell Rating, $29 PT for Autodesk
Goldman Sachs Reiterates Buy Rating, Does Not Name PT for Cisco Systems
Read More...
Goldman Sachs Group Inc. Recent News
UPDATE: Goldman Sachs Reiterates Buy Rating, Lowers PT for Qualcomm
UPDATE: Goldman Sachs Reiterates Buy Rating, Lowers PT for The Mosaic Company
UPDATE: Goldman Sachs Reiterates Sell Rating, Lowers PT for Intrepid Potash
UPDATE: Goldman Sachs Reiterates Buy Rating, Raises PT for CF Industries Holdings
UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT for Agrium
UPDATE: Goldman Sachs Reiterates Buy Rating, Raises PT for Edwards Lifesciences
UPDATE: Goldman Sachs Reiterates Sell Rating, Lowers PT for Safeway
Goldman Sachs Reiterates Sell Rating, $21 PT for Kroger
Goldman Sachs Reiterates Neutral Rating, $29 PT for Centene
UPDATE: Goldman Sachs Reiterates Neutral Rating, Lowers PT for Navistar International
UPDATE: Goldman Sachs Reiterates Neutral Rating, Lowers PT for Navistar International
Goldman Sachs Reiterates Buy Rating, $39 PT for Focus Media
UPDATE: Goldman Sachs Reiterates Buy Rating, Lowers PT for McDonald's
Goldman Sachs Reiterates Buy Rating, $38 PT for Marriott
UPDATE: Goldman Sachs Changes Status of CNH Global to Not Rated
UPDATE: Goldman Sachs Reiterates Buy Rating, Raises PT for Precision Castparts
UPDATE: Goldman Sachs Maintains Neutral Rating, Raises PT for Wal-Mart Stores
UPDATE: Goldman Sachs Reiterates Neutral Rating, Lowers PT for Alkermes
Goldman Sachs Maintains Neutral Rating, $33 PT for Schnitzer Steel Industries
UPDATE: Goldman Sachs Maintains Neutral Rating, Lowers PT for Intuit
Goldman Sachs Reiterates Neutral Rating, $170 PT for salesforce.com
UPDATE: Goldman Sachs Maintains Neutral Rating, Raises PT for Vertex Pharmaceuticals
UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT for Vitamin Shoppe
